Andras Forgacs is an entrepreneur and venture investor in technology and life sciences. He is the co-founder and CEO of Modern Meadow, a research stage company applying tissue engineering methods to develop a new class of biomaterials. In addition, Andras is a co-founder and director of Organovo (OTC: ONVO), a leader in tissue engineering which pioneered the use of 3D bio-printing to create human tissue for a range of medical applications. Organovo’s bio-printer was named one of the top inventions of 2010 by Time Magazine and the company was recognized by MIT Technology Review on its TR50 list of most innovative companies for 2012. Andras is also a Venture Partner with Richmond Global, an international early-stage fund focused on technology enabled services. In this role, Andras led investments in companies in the US and China including AdChina, Ushi, LearnVest, and Fiksu Mobile. Previously, Andras was a consultant in the New York office of McKinsey & Company focused on healthcare and private equity as well as a founding member of Citigroup’s corporate and investment banking e-commerce group. He is also a co-founder and Chair Emeritus of The Resolution Project. Andras is a Kauffman Fellow with the Center for Venture Education and a Term Member with the Council on Foreign Relations. Andras holds an MBA from the Wharton School of Business and a Bachelor of Arts with honors from Harvard University.